Don't miss

Replay


LATEST SHOWS

EYE ON AFRICA

Benin feels the pinch of Nigeria's economic woes

Read more

BUSINESS DAILY

Deutsche Bank shares recover after turbulent week

Read more

MEDIAWATCH

Inside Aleppo: 'Feels like prison'

Read more

THE WORLD THIS WEEK

The Legacy of Shimon Peres, The Battle of Aleppo (Part 1)

Read more

THE WORLD THIS WEEK

Trump-Clinton Debate, Colombia Peace Deal, Death of the BlackBerry (Part 2)

Read more

FRANCE IN FOCUS

Backstage at Paris Fashion Week

Read more

FASHION

Paris Fashion Week: Saint Laurent, Lanvin, present new designers

Read more

#THE 51%

Online and proud: Iranian women use social media in a campaign for equality

Read more

#TECH 24

Say hello to Pepper!

Read more

Americas

Obama earmarks $1.8 billion for fight against pandemic

Text by NEWS WIRES

Latest update : 2009-07-16

US President Barack Obama has designated more than $1.8 billion in emergency funds to fight a pandemic of influenza A(H1N1), or swine flu. The money will mainly go toward producing vaccines and helping plan immunisation campaigns.

REUTERS - President Barack Obama designated $1.825 billion on Thursday for emergency use to fight the new pandemic of H1N1 swine flu.

 

The money will go to buy vaccine ingredients, to help health officials plan immunization campaigns and to help get the vaccines approved at the U.S. Food and Drug Administration, Obama said in a letter to House of Representatives Speaker Nancy Pelosi.

 

"To enhance our nation's capability to respond to the potential spread of this outbreak, and in accordance with the appropriation, I hereby designate $1.825 billion of the contingent appropriation as emergency funds required to address critical needs related to emerging influenza viruses (specifically, the virus known as 2009-H1N1)," Obama wrote.

 

The money comes from $7.65 billion Congress already appropriated to the Department of Health and Human Services for the swine flu pandemic.

 

The World Health Organization said earlier on Thursday that the H1N1 flu pandemic was the fastest-moving ever and that it was now pointless to count every case.

 

WHO said at least 50 governments have placed orders for vaccines and WHO vaccine chief Marie-Paule Kieny told Reuters the potential global value of the market was estimated at between $10 billion and $20 billion.

 

 Sanofi-Aventis, Novartis, Baxter, GlaxoSmithKline, and AstraZeneca's MedImmune unit all have H1N1 vaccines for the U.S. market.

 

Date created : 2009-07-16

COMMENT(S)